The exocyst complex tethers vesicles at sites of fusion through interactions with small GTPases. The G protein RalA resides on Glut4 vesicles, and binds to the exocyst after activation by insulin, but must then disengage to ensure continuous exocytosis. Here we report that, after recognition of the exocyst by activated RalA, disengagement occurs through phosphorylation of its effector Sec5, rather than RalA inactivation. Sec5 undergoes phosphorylation in the G-protein binding domain, allosterically reducing RalA interaction. The phosphorylation event is catalysed by protein kinase C and is reversed by an exocyst-associated phosphatase.
and subjected to glucose-uptake assay. The error bars represent the s.e.m. of triplicate samples. Asterisk, P < 0.01. The experiment shown was representative of six independent repeats. (b) Constitutively active RalA upregulated glucose transport after depletion of endogenous RalA. 3T3-L1 adipocytes were pretreated for 72 h with RalA untranslated region siRNA by electroporation; GFP or constitutively active RalA (RalA G 23 V) was introduced into these cells by lentiviral expression. Cells were maintained in the basal state and subjected to glucose-uptake assay as in a. The error bars represent the s.e.m. * ,P < 0.05 (c) Constitutively active RalA does not increase proximal insulin signalling or expression levels of glucose transporters. Cell lysates from a were subjected to western blotting. The upper bands in RalA blotting represent exogenous forms. IB: immunoblotting. (d) Generation of active RalA mutants uncoupled from RalBP1 or the exocyst. Indicated Flag-tagged RalA mutants were expressed in adipocytes by lentivirus, and subjected to immunoprecipitation (IP) and western blotting with indicated antibodies. (e) Active RalA promotes glucose uptake through the exocyst. Adipocytes were infected with lentivirus expressing indicated proteins and subjected to glucose-uptake assay. The error bars represent the s.e.m. of triplicate samples. Asterisk, P < 0.05; double asterisk, P < 0.001. The experiment shown was representative of three independent repeats. (f) Uncoupling RalA from the exocyst does not affect GTP hydrolysis of the protein. Cells expressing the indicated RalA proteins were lysed and subjected to pulldown assay; RalA bound to GST protein (active) and in cell lysates (total) was determined by western blotting. When indicated, cell lysates were loaded with 1 mM GDP or 200 µM GTPγS. In the case of active RalA or RalA loaded with GTPγS, only 10% of the pulldown was subjected to western blotting analysis to ensure linear range signals. (g) Quantification of RalA GTP loading from four independent experiments as carried out in f. The error bars represent the s.d. Uncropped images of blots are shown in Supplementary Fig. S7 .
was depleted by RNA interference (Fig. 1b and Supplementary Fig. S1 ). The absence of alterations in proximal insulin signalling, or levels of the glucose transporters Glut4 and Glut1 (Fig. 1c) , suggested a selective effect on vesicle transport. To determine whether constitutively active RalA promotes glucose transport through the exocyst complex, we introduced point mutations into its effector domain to specifically uncouple active RalA from its effectors RalBP1 (RalA G23V/D49N ) or the exocyst (RalA G23V/D49E ) (Fig. 1d) . Interestingly, whereas RalA BP1 retained its ability to promote glucose transport, the exocyst-uncoupled RalA Exocyst failed to do so (Fig. 1e) , despite harbouring the consti-tutively active mutation G23V. Thus, whereas active RalA promotes glucose transport by binding to the exocyst, inactivation through GTP hydrolysis is not necessary for its displacement. Moreover, RalA G23V and RalA G23V/D49E maintained high GTP-bound ratios, comparable to those of wild-type RalA loaded with GTPγS. RalA D49E , which cannot interact with the exocyst, showed essentially the same GTP-bound ratio as did wild-type RalA (Fig. 1f,g ), suggesting that the exocyst does not promote GTP hydrolysis of RalA, unlike the Sar1-COPII complex 17, 18 . Taken together, the data pointed to an alternative, GAP-independent mechanism for disengagement from the exocyst during vesicle transport.
The RalA-interacting exocyst subunit Sec5 is phosphorylated to disengage the G protein
We considered whether modifications on the RalA effector Sec5, the exocyst subunit connecting RalA to the holo-complex ( Supplementary  Fig. S2a ) that marks exocytosis sites 9, 10 , might release RalA from the exocyst. The majority of the RalA-Sec5 interaction is initiated on intracellular membranes ( Supplementary Fig. S2b ), whereas the loss of plasma-membrane-associated exocyst had little effect on RalA-exocyst interaction under basal conditions or in the presence of the Ral guanine nucleotide exchange factor (GEF) Rlf ( Supplementary Fig. S2c,d ), further indicating a disengagement event before vesicle fusion at the plasma membrane.
Treatment of cells with the phosphatase inhibitor Calyculin A led to slower migration of Sec5 on SDS-polyacrylamide gel electrophoresis (PAGE; Fig. 2a ), indicating reversible phosphorylation. A [
32 P] orthophosphate-labelled phospho-protein corresponding to the size of Sec5 (relative molecular mass of 105,000, ∼M r 105K) was detected in exocyst immune complexes, and was reduced on Sec5 knockdown ( Supplementary Fig. S3a ). Haemagglutinin (HA)-tagged Sec5 was also 32 P-labelled in cells, in a manner markedly enhanced by Calyculin A treatment ( Supplementary Fig. S3b ). Moreover, serine/threonine (Ser/Thr) phosphatase activity was found with the exocyst (Supplementary Fig. S3c ), accounting for the stimulatory effect of Calyculin A on Sec5 phosphorylation.
Epidermal growth factor (EGF) enhanced phosphorylation of Sec5 in Cos-1 cells (Fig. 2b) , and also produced a concomitant recruitment of Sec5 to plasma membrane ruffles (Fig. 2c) , implying a functional role of the modification. Interestingly, Calyculin A, unlike EGF, did not translocate Sec5 to the plasma membrane, despite producing numerous membrane protrusions ( Supplementary Fig. S3d ), indicating that hormones might regulate Sec5 phosphorylation through kinase activation. EGF-stimulated Sec5 phosphorylation was also detected by an antibody that recognizes phosphorylated Ser/Thr following basic residues such as lysine or arginine ( Supplementary Fig. S4a ). Treatment of immunoprecipitated Sec5 with λ phosphatase eliminated reactivity of Sec5 with the p-Ser/Thr motif antibody ( Supplementary Fig. S4a ). Insulin also stimulated Sec5 phosphorylation in 3T3-L1 adipocytes ( Supplementary Fig. S4b) .
A series of Sec5 truncation constructs was generated to map the phosphorylated residues (Fig. 2d) . Deletion of the aminoterminal Ral-binding domain (RBD) of Sec5 greatly decreased EGF-stimulated phosphorylation, whereas the RBD alone underwent EGF-stimulated phosphorylation (Fig. 2e ). An alanine scan identified Ser 89 as the phosphorylation site (Fig. 2f) , confirmed by a reciprocal immunoprecipitation with the p-Ser/Thr motif antibody ( Supplementary Fig. S4c ) and metabolic labelling with 32 P orthophosphate ( Supplementary Fig. S4d ). Interestingly, further phosphorylation events on Sec5 were also observed.
Because the RBD of Sec5 is the RalA recognition site 11, 21 , we hypothesized that Ser 89 phosphorylation may modulate RalA interaction. We generated a phospho-null version of Sec5 RBD by mutation of Ser 89 to alanine (S89A), as well as a phospho-mimetic Sec5 RBD by mutation of Ser 89 to aspartic acid (S89D). Wild-type Sec5 RBD and the S89A mutant showed similar binding to active RalA, whereas the phospho-mimetic S89D mutant showed little interaction (Fig. 3a) . Similar results were observed in reciprocal experiments (Fig. 3b) . Together, these data suggest that phosphorylation of Ser 89 in the effector domain directly disrupts the Sec5-RalA interaction.
The incorporation of Sec5 into the exocyst is independent of RalA, but controlled by other exocyst subunits including Sec8 (unpublished data and ref. 22) . Furthermore, the levels of Sec5 are tightly controlled by other exocyst subunits, as stably expressed wild-type Sec5 caused a concomitant decrease of endogenous Sec5 (Fig. 3c) . Endogenous Sec5 was similarly replaced with both S89A and S89D mutants (Fig. 3c) . These results suggested that Sec5 Ser 89 phosphorylation does not alter its assembly with other exocyst proteins, despite its inhibitory role in RalA binding, confirming that the exocyst provides docking sites for RalA-localized vesicles.
We expressed different versions of Sec5 into adipocytes along with Myc-Glut4-eGFP (enhanced green fluorescent protein), and assessed immunostaining of the Myc tag without permeabilization of the adipocytes (reflecting Glut4 fusion). While wild-type Sec5 had little effect on insulin-stimulated Glut4 fusion with the plasma membrane, expression of Sec5 S89D markedly decreased Glut4 membrane fusion, consistent with the notion that RalA interaction is a prerequisite for exocyst function. Interestingly, expression of Sec5 S89A also inhibited Glut4 fusion (Fig. 3d,e) , suggesting that disengagement of Sec5 from RalA by Ser 89 phosphorylation is required for exocyst function.
Protein kinase C (PKC) catalyses Sec5 effector-domain phosphorylation
We generated a polyclonal phospho-specific antibody that specifically reacted with phospho-Ser 89 of Sec5, but not with Sec5 S89A ( Supplementary Fig. S4e,f) . Interestingly, the phospho-antibody recognizes Sec5 RBD S89D , but not the wild type or S89A form, thus confirming the phospho-mimetic property of the S89D substitution (Fig. 4a) . EGF-stimulated Ser 89 phosphorylation of Sec5 in Cos-1 cells was abolished by two different inhibitors of PKC, Gö6976 and Ro 31-8220, and partially blocked by the PI 3-kinase (phosphoinositide 3-kinase)/mTOR (mammalian target of rapamycin) kinase inhibitor wortmannin, but was largely unaffected by other kinase inhibitors (Fig. 4b) . Addition to cells of the phorbol ester tetradecanoyl phorbol acetate (TPA), an activator of PKCs, stimulated Sec5 Ser 89 phosphorylation (Fig. 4c) . The phosphorylation of Sec5 RBD was enhanced by PKCα expression, whereas the kinase-dead PKCα (PKCα K/R) partially blocked TPA-stimulated phosphorylation of Ser 89 (Fig. 4c) . Similar stimulation of phosphorylation by TPA was observed on endogenous Sec5, as determined by immunoprecipitation with the p-Ser 89 antibody (Fig. 4d) attenuated exocytosis of the Myc-Glut4-eGFP reporter after insulin stimulation (Fig. 4e,f) .
Conventional PKCs (α and β) directly phosphorylated Ser 89 on a glutathione S-transferase (GST)-Sec5 RBD fusion protein, but did not phosphorylate the S89A mutant, whereas the new PKC isoforms (δ and ε) produced only modest phosphorylation, and PKD/PKCµ was without effect (Fig. 4g) . GST-Sec5 RBD and its S89A mutant were incubated with recombinant PKCα plus ATP before immobilization on reduced glutathione (GSH) beads. The immobilized proteins were then subjected to pulldown to assess binding with active RalA. Phosphorylation of Sec5 on Ser 89 led to decreased RalA binding, and this effect was not observed in the S89A mutant (Fig. 4h) . When tested in vivo, TPA-stimulated Ser 89 phosphorylation in full-length Sec5 or Sec5 RBD led to a coincident decrease in RalA binding (Fig. 4i ). This effect of TPA was not observed in the S89A mutant (Fig. 4j) , despite increased binding to RalA. Thus, PKC-catalysed phosphorylation of Sec5 at Ser 89 in the effector domain reverses its interaction with RalA.
Allosteric phosphorylation on Sec5 contributes to cellular organization and organism development
We hypothesized that Sec5 effector-domain phosphorylation may serve as a general mechanism for exocyst function. Consistent with the reported role of exocyst proteins in abscission during the cell cycle 12, 13 , phosphorylated Sec5 is enriched in the abscission sites of the dividing daughter cells (Fig. 5a ). This phosphorylation may take place either within the interaction interface of RalA and Sec5, or at an allosteric site that causes a conformational change in the RBD. Examination of the Sec5 RBD structure 11, 21 revealed that Ser 89 does not occupy the RalA interaction interface 11 , but rather makes contacts with the acidic side-chain of an aspartic acid residue (Asp 73) in a flexible loop region 21 ( Fig. 5b ), suggesting that a negatively charged phospho-Ser 89 might repel the side-chain of Asp 73, reducing interaction with activated RalA. Substitution of Asp 73 in the RBD with a serine residue alleviated the inhibitory effect of the phospho-mimetic mutation S89D on RalA binding (Fig. 5c ), further indicating that Ser 89 phosphorylation of Sec5 allosterically inhibits its interaction with RalA.
We also carried out a reconstitution experiment to define the sequential order of the regulatory events. GST-Sec5 RBD was incubated with GTPγS-loaded His-RalA. The complex was separated from unbound RalA with GSH columns, and then incubated with activated PKC in the presence of ATP/magnesium. PKC catalysed Sec5 phosphorylation when bound to RalA, subsequently disengaging the two proteins (Fig. 5d) . Importantly, dissociated RalA underwent a second round of interaction with fresh, unphosphorylated Sec5 RBD, thus enabling the process to continue.
To determine whether RalA might potentiate Sec5 phosphorylation after its membrane recruitment, we generated a chimeric protein by fusing the carboxy-terminal membrane-targeting sequence of RalA with Sec5 RBD (RBD-CAAX, Supplementary Fig. S5a ); this chimera localized to RalA-residing membranes. Compared with cytosolic RBD, phosphorylation of the chimeric protein was enhanced ( Supplementary Fig. S5b ). Moreover, whereas Sec5 RBD S89D failed to co-immunoprecipitate with endogenous RalA, the S89A version of the Sec5 RBD showed increased binding in cells (Fig. 5e ), despite Immunoprecipitates and total cell lysates were fractioned by SDS-PAGE and were subjected to western blotting analysis with indicated antibodies. The arrows indicate exogenous Sec5 (upper band) and endogenous Sec5 (lower band). (d) Perturbation of Sec5 Ser 89 phosphorylation disrupts plasma membrane fusion of Glut4. Adipocytes were co-infected with lentivirus expressing the indicated Sec5 constructs and the Myc-Glut4-eGFP reporter at a 6:1 ratio for 3 weeks. Cells were starved for 4 h before stimulation with vehicle or 100 ng µl −1 insulin for 20 min and fixed with 10% formalin for 10 min without permeabilization before being subjected to immunostaining with Myc (red) antibody and confocal microscopy. Images were at the same magnification; bar = 10 µm. possessing a similar binding capacity in vitro (Fig. 3a,b) . A similar increase was observed with Flag-tagged, constitutively active RalA G23V ( Supplementary Fig. S5c ), ruling out potential effects on RalA GTP loading by RBDs, and further suggesting that the loss of Ser 89 phosphorylation leads to accumulation of RalA-bound Sec5. We then examined active RalA-residing vesicles that were directed to the regions of plasma membrane expansion, a process that involves the exocyst and cytoskeletal proteins 22, 24 . Wild-type Sec5 localized to vesicles bearing activated RalA G23V ; however, a portion of the vesicles showed little or decreased Sec5 localization when approaching the cell edge. In contrast, Sec5 S89A showed persistent co-localization to RalA-containing vesicles, even when these vesicles are targeted to long narrow protrusions of plasma membrane (Supplementary Fig. S5d ).
These data prompted us to further investigate the impact of these mutants on vesicle fusion by total internal reflective fluorescent microscopy. We introduced into Cos-1 cells pHluorin-tagged transferrin receptor (TfR), an exocyst-dependent cargo that also undergoes endocytic recycling 25 , with Sec5 S89A . The kinetics of exocytic fusion of pHluorin-TfR-containing vesicles were not significantly different from those in cells expressing wild-type Sec5 and the reporter (Fig. 5f ), consistent with the notion that tethering is distinct from fusion. Quantitative analysis revealed that Sec5 S89A expression decreased plasma membrane fusion events averaged by surface area and time (Fig. 5f , Supplementary Movies S1 and S2 and Table S1 ). These data further support the hypothesis that Sec5 phosphorylation disengages the interacting G protein to regulate the dynamics of the exocytic programme.
A survey of the Sec5 effector-domain sequence revealed more than 90% identity between humans and zebrafish, whereas the full-length proteins are ∼75% identical between the two organisms ( Supplementary Fig. S6a ). Furthermore, Ser 89 and its flanking sequences are highly conserved in several vertebrate organisms ( Supplementary Fig. S6b ). MDCK cells expressing wild-type Sec5 showed morphology and distribution of the tight junction marker ZO-1 identical to those of the neighbouring cells without the exogenous protein (Fig. 6a, top row) . However, replacement of endogenous Sec5 with either S89A or S89D Sec5 led to a disruption of cellular morphology and accumulation of multinucleated cells ( Fig. 6b ; Loss of exocyst function causes embryonic lethality in different organisms, including Drosophila and mouse 26, 27 , suggesting an evolutionarily conserved role of the complex during development. We thus hypothesized that loss of Sec5 may produce embryonic defects during the development of zebrafish, in which a single, non-duplicated orthologue of Sec5 was found. Injection of morpholino (MO) oligonucleotides that bind the 5 untranslated region of Sec5 messenger RNA into zebrafish embryos caused embryonic degeneration and lethality in a dose-dependent fashion ( Supplementary Fig. S6c) , with most embryos dead or severely deformed at MO concentrations greater than 0.5 mM. The defects could be attributed to loss of Sec5, as reintroducing the wild-type mouse Sec5 mRNA largely reversed the embryonic lethality caused by MO oligonucleotides (Fig. 6c,d ). Unlike the wild-type protein, neither S89A nor S89D Sec5 rescued the lethality resulting from loss of Sec5 (Fig. 6c,d) , further confirming the necessity of the Ser 89 phosphorylation cycle for exocyst function. Thus, we propose that phosphorylation of Sec5 drives its disengagement from RalA following vesicle recognition in a variety of physiological systems (Fig. 7) .
DISCUSSION
Regulated exocytosis requires the actions of distinct machineries to coordinate the sorting, trafficking, tethering, docking and fusion of exocytotic vesicles 28, 29 . The exocyst complex integrates the later stages of this process by tethering exocytic vesicles before their membrane fusion 1 , through interactions with several small GTPases, including RalA that directs the vesicle to the exocyst 4 . However, little is known about the mechanisms governing the disengagement of the exocyst from the G proteins. Here we present evidence that phosphorylation of the exocyst subunit Sec5 by PKC disassociates the effector protein from RalA, in the process ensuring the proper function of the exocyst.
The exocyst targets vesicles to specific domains of cells where the fusion apparatus is concentrated 1, 30 . While studies from yeast suggest that vesicle tethering by the exocyst may be closely coupled with the final membrane fusion 1, 31, 32 , the nature of this cooperative processes is poorly understood in higher organisms, particularly regarding the transition from long-range tethering factors to the assembly of relatively small SNARE fusion apparatus 1, 2 . In this regard, freeing vesicles from the tethering factor probably would maximize the chances of vesicle SNAREs (v-SNAREs) making contact with their cognate target SNAREs on the plasma membrane. A minimum of ∼150 embryos in total were phenotyped in a double-blind manner from three or four independent experiments (n = 4 for MO alone and wild type, n = 3 for mutants). The error bars represent the s.d. Uncropped images of blots are shown in Supplementary Fig. S7 .
While freeing the vesicles may offer advantages for fusion, disengagement of the G protein and the effector complex also frees the exocyst for the continuous flow of vesicles to the plasma membrane and maximizes the output of key transport machineries for rapid and efficient delivery of vesicles. Moreover, the exocyst complex is unlikely to be in excess over cargo molecules, especially those that undergo continuous recycling for sustained exocytosis such as Glut4 (ref. 33 ). Thus, Sec5 phosphorylation enables active recycling of the complex to continuously provide targeting signals for incoming vesicles. Hence, the exocyst may represent a limiting factor during regulated exocytosis, raising the possibility that the complex serves not only to target vesicles 32 but also as a 'gatekeeper' to control their access to the plasma membrane.
Conventional PKCs have long been recognized as key regulators of exocytosis, particularly in neuronal systems [34] [35] [36] . PKC activation increases the size of the ready release pool of synaptic vesicles 37, 38 , a process that also involves RalA and perhaps the exocyst 37 . Furthermore, the mammalian exocyst interacts with atypical PKC in regulating cell migration 39 , suggesting that other members of this kinase family might fine tune exocyst function through phosphorylation of Sec5 or other exocyst subunits. The ability of kinases to directly modulate the partner of the RalA GTPase bypasses the need for GAPs to disengage the tethering complex by inactivating RalA, thus reserving RalGAPs for regulating the G protein by upstream signals 40 . The precise roles of the various steps in insulin-stimulated glucose transport remain uncertain and controversial 33, 41, 42 . Insulin regulates exocyst assembly through activation of TC10 (ref. 5) , and induces its recognition of the Glut4 vesicle through stimulation of RalA (ref. 7) . We propose that, after activation of RalA by insulin 7 through the PI 3-kinase pathway that inactivates the RalGAP complex 40 , the G protein binds the exocyst complex through Sec5, thus directing the vesicle to sites on the plasma membrane where SNARE proteins assemble. After binding to Sec5 and localizing at or near the plasma membrane, this exocyst subunit undergoes phosphorylation on Ser 89, an event that allosterically disassociates Sec5 from RalA, probably facilitating the release of the vesicle from the exocyst for interaction with the t-SNARE proteins at the site of fusion. Once released from RalA, Sec5 is dephosphorylated by resident phosphatases, enabling the recognition of another vesicle through RalA. It is tempting to speculate that Sec5 phosphorylation represents the last regulated step in insulin-stimulated glucose transport, before an irreversible fusion process at the plasma membrane. 
METHODS

Methods
METHODS
DNA constructs. The mouse Sec5 complementary DNA in the pKH3 vector has been described before 7 . Alternatively, Flag or Myc tags were introduced into the same vector by replacing sequences encoding the HA tag. The truncation of Sec5 was constructed by polymerase chain reaction using specific primers and subcloned into the pKH3 vector. The RBD of Sec5 or RalBP1 was cloned into the pGEX 4T-2 vector. Point mutations of cDNAs were introduced by site-directed mutagenesis. GST-tagged wild-type and kinase-dead forms of PKCs in pEBG vectors were kindly provided by K. Inoki (University of Michigan). cDNA encoding Myc 7 -Glut4-eGFP was a generous gift from J. Bogan (Yale University), and was subcloned into a lentiviral vector. Other constructs have been described previously 7 . All constructs were fully sequenced at the University of Michigan sequencing core.
Antibodies and recombinant proteins. A phospho-specific antibody for the Ser 89 site on Sec5 was generated against a phospho-peptide (5 -CGKGTSTVpSFKLLKPEK-3 ) in rabbits (Pacific Immunology). Tandem affinity purification of the rabbit serum was carried out first with a non-phospho-peptide conjugated column and subsequently with a phospho-peptide conjugated column to specifically isolate the phospho-specific antibody. To eliminate cross-reaction with non-phosphorylated Sec5, the purified antibody was preabsorbed with GST-Sec5 RBD bound to nitrocellulose membranes before use at 1:500 for western blotting. The mouse monoclonal Sec5 antibody was provided by S-C. Hsu (Rutgers University) and has been described before 12 . Information regarding the commercial antibodies is included in the following section of commercial antibodies and enzymes. All the purified protein kinases were purchased from Cell Signaling Technology. GST-fusion proteins were expressed in BL21 DE3 cells through overnight induction at 20 • C with 0.1-0.2 mM isopropyl-β-D-thiogalactoside. Purification of recombinant GST proteins was carried out with GSH beads as previously described 7 .
Cell culture and lentiviral gene transduction. Growth and differentiation of 3T3-L1 adipocytes were carried out as previously reported 43 . Adipocytes stably expressing the Myc 7 -Glut4-eGFP reporter were maintained as previously described 7 . Cos-1, 293T and MDCK cells were grown in DMEM containing 10% fetal bovine serum and 1% Pen-Strip (Gibco). Cos-1 and MDCK cells were transfected with Fugene 6 reagent (Roche) according to the manufacturer's instruction. Stable clones of MDCK II cells were selected using 600 ng ml −1 G418 (Invitrogen) and maintained in 300 ng ml −1 G418. Chemical inhibitors were purchased from Calbiochem. Production of lentivirus was carried out in 293T cells essentially as described 43 . The conditioned medium containing viral particles was concentrated with a Centri-Prep Plus 70 (Millipore). Infection was carried out by spinning viral particles onto cells at 1,000 g for 45 min at room temperature in the presence of 8 µg ml −1 polybrene.
Pulldown, immunoprecipitation and western blotting. For pulldown experiments, cellular proteins were extracted with buffer A (100 mM Tris at pH 7.5, 1% NP-40, 10% glycerol, 130 mM sodium chloride, 5 mM magnesium chloride, 1 mM sodium vanadate, 1 mM sodium fluoride and 1 mM EDTA) supplemented with protease inhibitor tablets (Roche). After spinning at 16,000g in a 4 • C bench-top centrifuge for 10 min, supernatants were incubated with 10-20 µg of GST-fusion immobilized on GSH beads for 45-60 min. Immunoprecipitation was carried out with cellular proteins extracted with buffer B (100 mM Tris at pH 7.5, 1% Triton X-100, 10% glycerol, 130 mM sodium chloride, 10 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mM sodium fluoride and 1 mM EDTA) supplemented with protease inhibitor tablets (Roche), whereas sodium pyrophosphate was exchanged with 5 mM magnesium chloride to preserve interactions with endogenous RalA. Following SDS-PAGE, proteins were transferred onto nitrocellulose membranes and western blotting was carried out essentially as described before. In the case of detecting endogenous RalA in co-immunoprecipitation experiments, protein A-conjugated HRP was used to avoid cross-reaction with antibody light chains.
Kinase assays, metabolic labelling and 2-deoxy-glucose uptake assay. In vitro kinase assays were carried out at 30 • C for 20 min in 50 µl buffers containing 50 mM MOPS at pH 7.2, 50 mM sodium chloride, 25 mM β-glycerolphosphate, 10 mM magnesium chloride, 1 mM sodium vanadate, 1 mM sodium fluoride and 100 µM ATP. When indicated, 1-5 µCi of 32 P ATP was included in the kinase reaction. PKC lipid activator mix (Millipore) was supplemented in the reaction buffer according to the manufacturer's instruction. Kinase reactions were stopped by adding 4× SDS-PAGE sample buffer and boiling at 95 • C for 5 min. Following SDS-PAGE, the proteins were transferred to nitrocellulose membranes and further detected by autoradiograph or western blotting.
14 C-labelled 2-deoxy-glucose uptake assays were carried out as previously reported 20 . Student's t -test was used for statistical analysis.
In vitro reconstitution. Recombinant His-RalA was expressed in BL21 cells, initially purified by Ni-affinity column and eluted with 300 mM imidazole in PBS; imidazole-eluted protein was further purified by Superdex 200 gel filtration column. GST-Sec5 RBD was expressed in BL21 cells, initially purified by GSH-affinity column and eluted with 1 mg ml −1 GSH in PBS; GSH-eluted protein was further purified by Superdex 200 gel filtration column. His-RalA was loaded overnight at 4 • C with 200 µM GTPγS in the presence of 20 mM Tris (pH 7.5) and 1 mM EDTA; loading was stopped by adding 10 mM MgCl 2 for 30 min. RalA-Sec5 complex was formed by incubating His-RalA: GTPγS and GST-Sec5 RBD in ∼2:1 molar ratio at 4 • C for 4 h. The reaction was then passed through a GSH-spin column (GE Healthcare) and free His-RalA was washed away. The complex was then eluted by 1 mg ml −1 GSH in PBS, and was exchanged to kinase reaction buffer (50 mM HEPES, 25 mM sodium β-glycerolphosphate, 5 mM MgCl 2 and 1 mM CaCl 2 by using Centricon (YM-50, Millipore). Kinase reaction was carried out as described above at 37 • C for 1 h. RalA-Sec5 complex was immobilized by passing a GSH-spin column twice and washing with once with PBS, whereas flow-through was collected to analyse free RalA released from Sec5. The second round of interaction was analysed by incubating His-RalA in the flow-through (80%) with unphosphorylated GST-Sec5 RBD immobilized on GSH beads (GE Healthcare).
Immunofluorescence and microscopy. Cells were grown on glass coverslips and washed with PBS before fixation. After fixation with methanol at −20 • C for 3 min, cells were rehydrated in PBS, and then blocked with 1% BSA and 1% chicken albumin. For Myc-Glut4-eGFP experiments in adipocytes, cells were fixed with 10% formalin at room temperature for 10 min, neutralized with 100 mM glycine-PBS. Cells were blocked with 1% BSA and 1% chicken albumin in PBS for 1 h at room temperature before being subjected to immunostaining. Monoclonal Myc and HA antibody (Santa Cruz) were used at 1:500 dilution. Other antibodies have been described before. Alexa-Fluor conjugated goat anti-mouse/rabbit secondary antibodies, Alexa-Fluor conjugated phalloidin and Vector Shield mounting medium were from Molecular Probes. Confocal images were obtained using an inverted Olympus confocal microscope operated with the Fluoview300 program. For experiments with MDCK cells, epifluorescent images were taken using a Nikon Eclipse TE2000-U microscope operated with the Metamorph program. Cells were phenotyped blindly for quantification purposes. Digital images were finally processed with the entire microscopic field using Photoshop CS software.
RNA interference in mammalian cells and MO-mediated knockdown in zebrafish. Stealth short interfering RNA (siRNA; Invitrogen)-mediated knockdowns in mammalian cells were carried out as described. SiRNAs were transfected into Cos-1 cells using Lipofectamine2000 (Invitrogen) according to the manufacturer's instructions. Electroporations of siRNAs into adipocytes were carried out as previously reported; cells were collected for analysis 96 h post electroporation. MO oligonucleotides (5 -CCGAGACATCCTTCACACACTTTAC-3 , GeneTools) were designed to block the translation of mRNA of zebrafish Sec5. Zebrafish (Danio rerio) were raised as previously described in accordance with animal care guidelines. mMessage mMachine SP6 kits (Ambion) were used to generate mRNAs through in vitro transcription using pKH3 Sec5 constructs. Injection of zebrafish embryos was carried out as previously reported 44 . Embryos were phenotyped in a double-blind fashion for lethality 24 h post injection or degeneration at 72-96 h post fertilization (hpf).
Statistical analysis. Student's t -test was used for statistical analysis.
Commercial antibodies and enzymes. Monoclonal p-tyrosine (4G10) antibody was purchased from Millipore and used at 1:2000 dilution; monoclonal HA (F-7), Myc (9E10) and p-Erk antibodies were purchased from Santa Cruz Biotechnology; monoclonal Sec8 and Sec6 antibodies were purchased from Stressgen and used at 1;1,000 dilution; monoclonal RalA antibody was purchased from BD Biosciences and used at 1:1,000; Flag antibody (M2)-conjugated beads and polyclonal Flag antibody were purchased from Sigma; polyclonal p-Akt (Ser473), p-Ser/Thr motif (catalogue no. 9611), p-PKC (catalogue no. 9371), Rictor and PKCα antibodies were purchased from Cell Signaling Technology and used at 1:500 dilution; polyclonal antibodies for Glut1 and Glut4 were purchased from Alpha Diagnostics and used at 1:500 dilution. Protein-A-conjugated beads were purchased from Roche. λ phosphatase was purchased from NEB.
Stealth siRNA oligonucleotides. Sense sequences of siRNA oligonucleotides for the indicated protein from different organisms are listed below. To achieve efficient knockdown and limit off-target effects, a pool of siRNA oligonucleotides was used by mixing three or four different siRNAs at equal concentration. RNA interference for Sec8 and RalA has been previously reported 7, 20 . Pull-down and cell lysates were subjected to SDS-PAGE and western blot against indicated proteins. RalA levels in the total cell lysate dropped due to loss of plasma membrane localized RalA, but the exocyst proteins remained unchanged. 32 P metabolic labeling of Sec5. Cos-1 cells were pre-incubated in phosphate-free medium for 2 hours before labeling with 1mCi of ortho-phosphate ( 32 P) for 2 hours. Cell lysates were subjected to immunoprecipitation (IP) with the indicated antibodies. After separation on SDS-PAGE, phosphate incorporation was detected by autoradiography (left), whereas total protein was determined by WB with specific antibodies (right). Where indicated, cells were treated with siRNA to knock down cellular Sec5. The numbers indicate relative band intensities determined by ImageJ. (b) 32 P metabolic labeling of recombinant Sec5. Cos-1 cells expressing empty vector or HA-tagged Sec5 were labeled with ortho-phosphate (32 P) as in (a), and subjected to IP with HA antibody. After being separated on SDS-PAGE, phosphate incorporation was detected by autoradiography and total Sec5 protein was determined by WB using HA 
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